Cargando…

Plasma growth differentiation factor 15: a novel tool to detect early changes of hereditary transthyretin amyloidosis

AIMS: Hereditary transthyretin (ATTRv) amyloidosis is the most frequent and representative form of autosomal dominant hereditary systemic amyloidosis. Disease‐modifying treatments of the disease are more effective during the early stages, and we require biomarkers to detect early pathological change...

Descripción completa

Detalles Bibliográficos
Autores principales:	Okada, Masamitsu, Misumi, Yohei, Masuda, Teruaki, Takashio, Seiji, Tasaki, Masayoshi, Matsushita, Hiroaki, Ueda, Akihiko, Inoue, Yasuteru, Nomura, Toshiya, Nakajima, Makoto, Yamashita, Taro, Shinriki, Satoru, Matsui, Hirotaka, Tsujita, Kenichi, Ando, Yukio, Ueda, Mitsuharu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8006664/ https://www.ncbi.nlm.nih.gov/pubmed/33381924 http://dx.doi.org/10.1002/ehf2.13176

Ejemplares similares

New simple and quick method to analyze serum variant transthyretins: direct MALDI method for the screening of hereditary transthyretin amyloidosis
por: Nomura, Toshiya, et al.
Publicado: (2019)

Urinary Transthyretin as a Biomarker in ATTRv Val50Met Amyloidosis
por: Matsushita, Hiroaki, et al.
Publicado: (2022)

Hereditary ATTR Amyloidosis with Cardiomyopathy Caused by the Novel Variant Transthyretin Y114S (p.Y134S)
por: Nakase, Taku, et al.
Publicado: (2019)

Recent advances in transthyretin amyloidosis therapy
por: Ueda, Mitsuharu, et al.
Publicado: (2014)

Inflammatory state exists in familial amyloid polyneuropathy that may be triggered by mutated transthyretin
por: Suenaga, Genki, et al.
Publicado: (2017)

Detection of Vascular Notch3 Deposits in Unfixed Frozen Skin Biopsy Sample in CADASIL
por: Ueda, Akihiko, et al.
Publicado: (2022)

Non‐Val30Met mutation, septal hypertrophy, and cardiac denervation in patients with mutant transthyretin amyloidosis
por: Hirakawa, Kyoko, et al.
Publicado: (2018)

Glavonoid, a possible supplement for prevention of ATTR amyloidosis
por: Matsushita, Hiroaki, et al.
Publicado: (2021)

Development of transgenic Caenorhabditis elegans expressing human transthyretin as a model for drug screening
por: Tsuda, Yukimoto, et al.
Publicado: (2018)

Temporal Change in Longitudinal Strain After Domino Liver Transplantation With Liver Grafts Explanted From Patients With Hereditary Amyloidogenic Transthyretin Amyloidosis
por: Usuku, Hiroki, et al.
Publicado: (2020)

Amyloid fibril formation is suppressed in microgravity
por: Matsushita, Hiroaki, et al.
Publicado: (2020)

Diagnostic utility of cardiac troponin T level in patients with cardiac amyloidosis
por: Takashio, Seiji, et al.
Publicado: (2017)

Step‐by‐step typing for the accurate diagnosis of concurrent light chain and transthyretin cardiac amyloidosis
por: Moriyama, Hidenori, et al.
Publicado: (2022)

Can myocardial susceptibility quantification be an imaging biomarker for cardiac amyloidosis?
por: Hayashi, Hidetaka, et al.
Publicado: (2021)

Reversible Periventricular Hyperintensity Lesions in Cerebral Amyloid Angiopathy: A Case Mimicking Cerebral Amyloid Angiopathy-related Inflammation
por: Inoue, Yasuteru, et al.
Publicado: (2022)

Current Management and Therapeutic Strategies for Cerebral Amyloid Angiopathy
por: Inoue, Yasuteru, et al.
Publicado: (2021)

Usefulness of automatic assessment for longitudinal strain to diagnose wild-type transthyretin amyloid cardiomyopathy
por: Usuku, Hiroki, et al.
Publicado: (2023)

Optimal practices for the management of hereditary transthyretin amyloidosis: real-world experience from Japan, Brazil, and Portugal
por: Ando, Yukio, et al.
Publicado: (2023)

Prognostic value of left atrial strain in patients with wild‐type transthyretin amyloid cardiomyopathy
por: Oike, Fumi, et al.
Publicado: (2021)

Clinical characteristics, outcome, and therapeutic effect of tafamidis in wild‐type transthyretin amyloid cardiomyopathy
por: Takashio, Seiji, et al.
Publicado: (2023)

Correlation Between Cardiac Images, Biomarkers, and Amyloid Load in Wild‐Type Transthyretin Amyloid Cardiomyopathy
por: Morioka, Mami, et al.
Publicado: (2022)

Time-dependent change of relative apical longitudinal strain index in patients with wild-type transthyretin amyloid cardiomyopathy
por: Usuku, Hiroki, et al.
Publicado: (2022)

Early Progression of Aortic Stenosis Associated With Iatrogenic Variant Transthyretin Amyloidosis After Domino Liver Transplantation
por: Hosoda, Yasuhito, et al.
Publicado: (2020)

Prognostic value of right ventricular global longitudinal strain in patients with immunoglobulin light-chain cardiac amyloidosis
por: Usuku, Hiroki, et al.
Publicado: (2023)

Usefulness of quantitative (99m)Tc-pyrophosphate SPECT/CT for predicting the prognosis of patients with wild-type transthyretin cardiac amyloidosis
por: Ogasawara, Kouji, et al.
Publicado: (2022)

First Nationwide Survey of 199 Patients with Amyloid A Amyloidosis in Japan
por: Okuda, Yasuaki, et al.
Publicado: (2018)

Evolving landscape in the management of transthyretin amyloidosis
por: Hawkins, Philip N., et al.
Publicado: (2015)

Utility of left atrial and ventricular strain for diagnosis of transthyretin amyloid cardiomyopathy in aortic stenosis
por: Oike, Fumi, et al.
Publicado: (2022)

Diagnosis and management of transthyretin familial amyloid polyneuropathy in Japan: red-flag symptom clusters and treatment algorithm
por: Sekijima, Yoshiki, et al.
Publicado: (2018)

A simple staging system using biomarkers for wild‐type transthyretin amyloid cardiomyopathy in Japan
por: Nakashima, Naoya, et al.
Publicado: (2022)

Characteristics of Patients with Late- vs. Early-Onset Val30Met Transthyretin Amyloidosis from the Transthyretin Amyloidosis Outcomes Survey (THAOS)
por: Waddington-Cruz, Márcia, et al.
Publicado: (2021)

Correction to: Diagnosis and management of transthyretin familial amyloid polyneuropathy in Japan: red-flag symptom clusters and treatment algorithm
por: Sekijima, Yoshiki, et al.
Publicado: (2019)

Prediction of Medium-Term Mortality in Japanese Patients With Wild-Type Transthyretin Amyloidosis
por: Ochi, Yuri, et al.
Publicado: (2020)

Involvement of Macrophages in the Pathogenesis of Familial Amyloid Polyneuropathy and Efficacy of Human iPS Cell-Derived Macrophages in Its Treatment
por: Suenaga, Genki, et al.
Publicado: (2016)

Clinical characteristics and natural history of wild‐type transthyretin amyloid cardiomyopathy in Japan
por: Yamada, Toshihiro, et al.
Publicado: (2020)

Hereditary cardiac amyloidosis associated with Pro24Ser transthyretin mutation: a case report
por: Yamamoto, Hiroyuki, et al.
Publicado: (2018)

Wild-type Transthyretin Amyloidosis with Diffuse Alveolar-septal Amyloidosis Diagnosed by a Transbronchial Lung Biopsy
por: Ishida, Masaki, et al.
Publicado: (2022)

Wild-type transthyretin amyloid cardiomyopathy complicated by spinal canal stenosis, carpal tunnel syndrome, and rotator cuff tears: a case report
por: Takashio, Seiji, et al.
Publicado: (2020)

Loss of gastric interstitial cells of Cajal in patients with hereditary transthyretin amyloidosis
por: Wixner, Jonas, et al.
Publicado: (2013)

Guideline of transthyretin-related hereditary amyloidosis for clinicians
por: Ando, Yukio, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_b8vfa7fbjurd8ghd0quhe06ejd